Synthesis and Evaluation of Serinolamide Derivatives as Sphingosine-1-Phosphate-1 (S1P₁) Receptor Agonists.

ABSTRACT: Sphingosine-1-phosphate-1 (S1P₁) receptor agonists are well-known drugs for treating multiple sclerosis (MS) caused by autoreactive lymphocytes that attack the myelin sheath. Therefore, an effective therapeutic strategy is to reduce the lymphocytes in the blood by inducing S1P₁ receptor internalization. We synthesized serinolamide A, a natural product of the sea, and performed S1P₁ receptor internalization assay to evaluate functionally antagonistic S1P₁ receptor agonist activity. In order to synthesize derivatives with better efficacy than serinolamide A and B, new derivatives were synthesized by introducing the phenyl ring moiety of fingolimod. Among them, compounds 19 and 21 had superior S1P₁ agonistic effects to serin

SUBMITTER: Park SJ 

PROVIDER: S-EPMC9101607 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature